Brinker Capital Investments’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Brinker Capital Investments's ATRC Position: Q2 2026 in Review
Brinker Capital Investments reduced its AtriCure (ATRC) stake by 5.5% in Q2 2026, selling an estimated $89.8K and leaving 55,105 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #936.
Brinker Capital Investments first reported a position in ATRC in Q3 2020 and has held it in 24 quarters since. The position peaked at $8.04M in Q3 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Brinker Capital Investments held 55,105 shares of AtriCure worth $1.54M as of Q2 2026.
- Brinker Capital Investments sold 3,192 AtriCure shares in Q2 2026, an estimated $89.8K.
- AtriCure made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #936 holding.
- Brinker Capital Investments first reported a position in AtriCure in Q3 2020 and has held it in 24 quarters since.
- Brinker Capital Investments's AtriCure position peaked at $8.04M in Q3 2021.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.